HomeABDXF • OTCMKTS
add
Abingdon Health PLC
Previous close
$0.070
Year range
$0.070 - $0.070
Market cap
12.07M GBP
P/E ratio
-
Dividend yield
-
Primary exchange
LON
Market news
CNBC
1 hour ago
S&P 500 futures slip after index posts longest win streak since November: Live updates
0.58%
0.75%
Financials
Income Statement
Revenue
Net income
| (GBP) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 1.55M | 28.38% |
Operating expense | 1.71M | 24.54% |
Net income | -1.26M | -109.21% |
Net profit margin | -81.48 | -62.96% |
Earnings per share | — | — |
EBITDA | -982.00K | -66.58% |
Effective tax rate | 4.25% | — |
Balance Sheet
Total assets
Total liabilities
| (GBP) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 3.67M | 83.73% |
Total assets | 9.82M | 103.69% |
Total liabilities | 3.40M | 13.07% |
Total equity | 6.42M | — |
Shares outstanding | 375.95M | — |
Price to book | 3.50 | — |
Return on assets | -28.39% | — |
Return on capital | -37.53% | — |
Cash Flow
Net change in cash
| (GBP) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -1.26M | -109.21% |
Cash from operations | -1.10M | -82.99% |
Cash from investing | -570.50K | -28,625.00% |
Cash from financing | 2.78M | 13,044.19% |
Net change in cash | 1.12M | 280.21% |
Free cash flow | -547.19K | -65.00% |
About
Abingdon Health is a leading international developer, manufacturer and distributor of lateral flow assay diagnostic tests, sometimes called rapid tests, lateral flow immunoassays, lateral flow tests or quick tests. Since its formation in 2008, Abingdon Health has developed and manufactured lateral flow rapid tests across multiple industries. Headquartered in York, with sites in Doncaster and Madison, USA. Wikipedia
CEO
Founded
Jan 1, 2008
Website
Employees
113
